Key result
ADA guidelines endorse aspirin for primary prevention in diabetic patients aged >40 or with CV risk.
The American Diabetes Association (ADA) has released a Standards of Medical Care in Diabetes Position Statement for 2008 (1). In this document, it is stated that aspirin therapy should be used as a primary prevention strategy in diabetic patients at increased cardiovascular (CV) risk, including those who are >40 years old or have additional risk factors. The recommendation is based on evidence graded “A,” which is defined by the ADA as “evidence from well-conducted, randomized controlled trials that are adequately powered or compelling nonexperimental evidence.” As this indication seemed very …
No takes yet. Share an insight, caveat, or question.
Dora et al. (2008) conducted an editorial in Diabetes. Aspirin therapy was evaluated. The 2008 ADA Standards of Medical Care position statement recommends aspirin therapy for primary prevention in diabetic patients >40 years old or with additional cardiovascular risk factors.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: